Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Spectrum of skin changes secondary to insulin injections in Type 1 diabetes mellitus patients.

Sawatkar GU, Kanwar AJ, Dogra S, Bhadada SK, Dayal D.

J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1321-3. doi: 10.1111/jdv.12068. Epub 2013 Jan 9. No abstract available.

PMID:
23302026
2.

Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.

Blanco M, Hernández MT, Strauss KW, Amaya M.

Diabetes Metab. 2013 Oct;39(5):445-53. doi: 10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22.

PMID:
23886784
3.

Impaired absorption of insulin aspart from lipohypertrophic injection sites.

Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, Lins PE.

Diabetes Care. 2005 Aug;28(8):2025-7. No abstract available.

PMID:
16043749
4.

Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

Bantle JP, Neal L, Frankamp LM.

Diabetes Care. 1993 Dec;16(12):1592-7.

PMID:
8299455
5.

Lipohypertrophy--a complication of insulin injections.

de Villiers FP.

S Afr Med J. 2005 Nov;95(11):858-9. No abstract available.

6.

Continuous subcutaneous insulin infusion therapy: effects on quality of life.

Scheidegger U, Allemann S, Scheidegger K, Diem P.

Swiss Med Wkly. 2007 Aug 25;137(33-34):476-82.

PMID:
17990132
7.

Atypical hypodermic necrosis secondary to insulin injection: a case report and review of the literature.

Caucanas M, Heureux F, Müller G, Vanhooteghem O.

J Diabetes. 2011 Mar;3(1):19-20. doi: 10.1111/j.1753-0407.2010.00103.x. Review. No abstract available.

8.

Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum.

Toth EL, Boychuk LR, Kirkland PA.

Diabetes Care. 1995 Sep;18(9):1284-5. No abstract available.

PMID:
8612446
9.

Leukocytoclastic vasculitis induced by subcutaneous injection of human insulin in a patient with type 1 diabetes and essential thrombocytemia.

Mandrup-Poulsen T, Mølvig J, Pildal J, Rasmussen AK AK, Andersen L, Skov BG, Petersen J.

Diabetes Care. 2002 Jan;25(1):242-3. No abstract available.

PMID:
11772924
10.

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.

Becker RH, Frick AD, Nosek L, Heinemann L, Rave K.

Diabetes Care. 2007 Oct;30(10):2506-7. Epub 2007 Aug 3. No abstract available.

PMID:
17675541
11.

Insulin pumps in young children.

Fuld K, Conrad B, Buckingham B, Wilson DM.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S67-71. doi: 10.1089/dia.2009.0182.

PMID:
20515310
12.

Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.

Heise T, Nosek L, Dellweg S, Zijlstra E, Præstmark KA, Kildegaard J, Nielsen G, Sparre T.

Diabetes Obes Metab. 2014 Oct;16(10):971-6. doi: 10.1111/dom.12304. Epub 2014 May 11.

PMID:
24720741
14.

Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.

Jeandidier N, Pinget M, Keipes M, Louy S, Vetter A, Réville P.

Transplant Proc. 1992 Jun;24(3):948-9. No abstract available.

PMID:
1604678
15.
16.

[Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].

Biesenbach G, Grafinger P, Kaiser W, Stuby U, Zazgornik J.

Med Klin (Munich). 1988 May 27;83(12):398-401. German. No abstract available.

PMID:
3043159
17.

The suboptimal roadmap to the intensive therapy target.

Davidson P, Hebblewhite H, Steed RD, Bode B.

Diabetes Technol Ther. 2004 Feb;6(1):17-9. No abstract available.

PMID:
15000765
18.

Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.

Lepore G, Dodesini AR, Nosari I, Trevisan R.

Diabetes Care. 2005 Jul;28(7):1834-5. No abstract available.

PMID:
15983352
19.
20.

[Clinical aspects of Insulin Lispro (LY275585)].

Kuzuya T.

Nihon Rinsho. 1997 Nov;55 Suppl:298-305. Review. Japanese. No abstract available.

PMID:
9434484

Supplemental Content

Support Center